Fertifa, named after its mission of providing “Fertility For All”, has secured £1 million in financing from venture capital firm, Passion Capital, and strategic angel investors. The new round of funding will accelerate Fertifa’s growth in the UK and Europe while enhancing the company’s tech-enabled platform – a digital portal for patients to access innovative, telehealth solutions designed to offer holistic, patient-centric care.
“Fertility challenges affect one in six couples in the UK. That’s 3.5 million people. Furthermore, one in four women experience a miscarriage, every LGBT+ employees requires support to become a parent and women are increasingly empowered to take control of the reproductive health through fertility preservation treatment,” comments Tony Chen, Founder and CEO of Fertifa.
The global fertility services market is expected to rise from its initial estimated value of $20 million in 2018 to an estimated value of $41 million by 2026. Employer funded fertility treatment is increasingly commonplace in the US – with companies such as Progyny and Carrot showcasing the importance for employers to adopt these benefits. While the UK is lagging behind, Fertifa provides a timely solution.
Employee wellbeing has risen to the top of the corporate agenda. Given the impact on every pillar of wellbeing (financial, mental and physical), a comprehensive fertility benefit really is the missing piece of the employee health and wellbeing puzzle. Fertifa exists to break down the taboo, providing a holistic corporate solution to fill this gap in. As a digital, next-generation fertility clinic, Fertifa’s mission is to provide accessible and affordable treatment that focuses on quality patient-centric care, clinical excellence and maximising clinical pregnancy rates.